Tag Archives: first for at-home use

The United States on Wednesday authorised Pfizer Inc’s antiviral Covid-19 pill for people ages 12 and older at risk of severe illness, the first oral and at-home treatment as well as a new tool against the fast-spreading Omicron variant. Pfizer’s antiviral regimen, Paxlovid, was nearly 90 per cent effective in preventing hospitalisations and deaths in patients at high risk of …

Read More »